AGL 40.39 Increased By ▲ 0.38 (0.95%)
AIRLINK 127.70 Decreased By ▼ -0.29 (-0.23%)
BOP 6.62 Increased By ▲ 0.02 (0.3%)
CNERGY 4.51 Decreased By ▼ -0.09 (-1.96%)
DCL 8.56 Increased By ▲ 0.08 (0.94%)
DFML 41.90 Increased By ▲ 0.42 (1.01%)
DGKC 87.25 Increased By ▲ 0.67 (0.77%)
FCCL 32.60 Increased By ▲ 0.46 (1.43%)
FFBL 65.21 Decreased By ▼ -0.21 (-0.32%)
FFL 10.22 Decreased By ▼ -0.03 (-0.29%)
HUBC 109.50 Decreased By ▼ -0.99 (-0.9%)
HUMNL 14.58 Decreased By ▼ -0.17 (-1.15%)
KEL 5.13 No Change ▼ 0.00 (0%)
KOSM 7.53 Increased By ▲ 0.41 (5.76%)
MLCF 41.62 Decreased By ▼ -0.03 (-0.07%)
NBP 59.57 Decreased By ▼ -0.52 (-0.87%)
OGDC 194.25 Decreased By ▼ -0.44 (-0.23%)
PAEL 28.18 Increased By ▲ 0.23 (0.82%)
PIBTL 7.83 Decreased By ▼ -0.17 (-2.13%)
PPL 152.00 Increased By ▲ 0.83 (0.55%)
PRL 26.58 Decreased By ▼ -0.30 (-1.12%)
PTC 16.05 Increased By ▲ 0.05 (0.31%)
SEARL 82.65 Increased By ▲ 4.45 (5.69%)
TELE 7.49 Increased By ▲ 0.10 (1.35%)
TOMCL 35.40 Decreased By ▼ -0.27 (-0.76%)
TPLP 8.20 Increased By ▲ 0.29 (3.67%)
TREET 16.12 Increased By ▲ 0.23 (1.45%)
TRG 52.63 Decreased By ▼ -0.13 (-0.25%)
UNITY 26.60 Increased By ▲ 0.05 (0.19%)
WTL 1.24 Decreased By ▼ -0.03 (-2.36%)
BR100 9,931 Increased By 10.4 (0.1%)
BR30 30,791 Increased By 39.6 (0.13%)
KSE100 93,569 Increased By 344.9 (0.37%)
KSE30 28,995 Increased By 110.6 (0.38%)
World

EU regulator backs month-long storage of Pfizer COVID-19 vaccine in fridges

  • Unopened thawed vials can be stored 31 days at 2C-8C.
  • Change following assessment of additional stability study data.
  • EMA says change to have 'significant' impact on rollout in EU.
Published May 17, 2021

Europe's drug regulator on Monday recommended extending the storage time for the Pfizer-BioNTech COVID-19 vaccine at normal fridge temperatures to 31 days from five days, easing logistical challenges during rollouts in the region.

The change is applicable to unopened vials, the European Medicines Agency (EMA) said, adding that the advice by its human medicines committee came after assessing additional stability study data submitted by Pfizer and BioNTech.

"EMA is in continuous dialogue with the marketing authorisation holders of COVID-19 vaccines as they seek to make manufacturing improvements to enhance vaccine distribution in the EU," the watchdog said.

The EU has allowed for ramped-up production of the Pfizer-BioNTech vaccine in the region and is eyeing a new deal to secure more doses of the shot after the bloc was hit by cuts in the supply of AstraZeneca's vaccine.

Vaccine deliveries were also slower initially under the EU's centralised procurement strategy.

US authorities in February had approved storage and transport of the Pfizer-BioNTech vaccine at standard freezer temperatures of -15 to -25 degrees Celsius for up to two weeks instead of the ultra-cold temperatures between -80 to -60 degrees Celsius it usually requires.

The EU storage change also comes as the US and German drugmakers are seeking approval of the vaccine for inoculating adolescents aged 12 to 15 years. The United States and Canada have started vaccinating this group with the shot, which uses the brand name Comirnaty.

The two-dose vaccine, similar to the one developed by Moderna, uses new mRNA technology to deliver instructions to the human body to build immunity against COVID-19.

With 200 million vaccine doses delivered overall, the EU is on track to achieve its goal of inoculating 70% of its adult population by summer, European Commission President Ursula von der Leyen tweeted on May 9.

Comments

Comments are closed.